Genomic Profiling Systems, Inc. Receives National Institute of Allergy, Infectious Disease Funds To Continue Development Of Emergency Diagnostic Testing Platform
10/19/2005 5:09:08 PM
Genomic Profiling Systems Incorporated (GPS) announced today that it would receive a three-year $4.1 million Phase II SBIR grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop a "surge" testing platform for rapid and ultra-sensitive diagnosis of anthrax. The MultiPath(TM) system will enable emergency testing on a mass scale, as would occur following a major biowarfare attack. According to the company, the platform will also be useful for key clinical and industrial applications including flu testing and detection of pathogens in food.
comments powered by